Promising new drug aims to halt rare bone disease FOP

NCT ID NCT05090891

Recruiting now Disease control Sponsor: Incyte Corporation Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times

Summary

This study tests an experimental drug called INCB000928 in people with fibrodysplasia ossificans progressiva (FOP), a rare condition where soft tissues turn into bone. The goal is to see if the drug can prevent or reduce new abnormal bone growth. About 98 participants aged 2 and older will receive either the drug or a placebo, and results will be measured using whole-body CT scans.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Albert Einstein Israelite Hospital
RECRUITING

São Paulo, 05652-900, Brazil
Amsterdam Umc - Vu Medisch Centrum (Vumc)
RECRUITING

Amsterdam, 1081 HV, Netherlands
Ap-Hp Hopital Lariboisiere
RECRUITING

Paris, 75010, France
Beijing Childrens Hospital Capital Medical University
RECRUITING

Beijing, 100045, China
Centro de Estudios Reumatologicos
RECRUITING

Santiago, 7501126, Chile
Children'S Hospital of Philadelphia
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Childrens Hospital of Fudan University
RECRUITING

Shanghai, 201102, China
Groote Schuur Hospital Radiation Oncology
RECRUITING

Cape Town, 07925, South Africa
Hopital Necker-Enfants Malades
RECRUITING

Paris, 75015, France
Hospital Italiano de Buenos Aires
NOT_YET_RECRUITING

Ciudad Autonoma Buenos Aires, C1199ABB, Argentina
Hospital Universitario Ramon Y Cajal
RECRUITING

Madrid, 28034, Spain
Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra
RECRUITING

Tlalpan, 14389, Mexico
Mayo Clinic Rochester
RECRUITING

Rochester, Minnesota, 55905, United States
Murdoch Children'S Research Institute
RECRUITING

Parkville, Victoria, 03052, Australia
Ospedale Pediatrico G. Gaslini
WITHDRAWN

Genova, 16147, Italy
Penn Medicine - Perelman Center For Advanced Medicine
ACTIVE_NOT_RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Policlinico Universitario Agostino Gemelli Universita Cattolica Del Sacro Cuore
RECRUITING

Rome, 00168, Italy
Royal Manchester Childrens Hospital - Department of Paediatric Endocrinology
WITHDRAWN

Manchester, M13 9PL, United Kingdom
Royal National Orthopaedic Hospital
RECRUITING

Stanmore, HA7 4LP, United Kingdom
Royal North Shore Hospital
COMPLETED

St Leonards, New South Wales, 02065, Australia
Seoul National University Hospital
ACTIVE_NOT_RECRUITING

Seoul, 03080, South Korea
Shanghai Childrens Medical Center
RECRUITING

Shanghai, 200127, China
Starship Childrens Hospital
RECRUITING

Auckland, 01023, New Zealand
Tongji Hospital of Tongji University
RECRUITING

Shanghai, 200065, China
Uniklinik Koln
RECRUITING

Cologne, 50931, Germany
University Health Network Toronto General Hospital
ACTIVE_NOT_RECRUITING

Toronto, Ontario, M5G 2C4, Canada
University of California San Francisco Medical Center
WITHDRAWN

San Francisco, California, 94143, United States

Conditions

Explore the condition pages connected to this study.

FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP)